Zirconium Zr 89 Girentuximab

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Clear Cell Renal Cell Carcinoma

Drug Information

Target Indication

Clear Cell Renal Cell Carcinoma

Clinical Trial

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

TLX

Telix Pharmaceuticals Ltd

Related Pipeline

Metastatic Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Biochemical Recurrence of Malignant Neoplasm of Prostate

Clear Cell Renal Cell Carcinoma

Advanced Cancer

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts